UNSPSC 51241135: Unoprostone isopropyl

This classification denotes a prostaglandin analogue and anti-glaucoma agent with the molecular formula C25H44O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5M161S5O5P, chemically known as isopropyl (5z,9alpha,11alpha)-9,11-dihydroxy-15-oxo-20a,20b-dihomoprost-5-en-1-oate but more generally known as isopropyl unoprostone, which bears US NIH Compound Identifier 5282175. European Medicines Agency schedules Unoprostone isopropyl in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15658MIG.

UNSPSC 51241135 Unoprostone isopropyl, a Commodity code, covers pharmaceutical products supplied to state and local government healthcare facilities through cooperative purchasing agreements. State and local governments use this code to procure generic and brand-name medications, including ophthalmic agents like unoprostone isopropyl, through established wholesaler networks and multi-source supplier contracts that standardize pricing, product identification, compliance documentation, and delivery logistics across participating jurisdictions.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and over-the-counter products distributed across participating state and local government facilities in Minnesota, Oregon, and other member states. The solicitation requires vendors to supply products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and demands certification of current Good Manufacturing Practices (cGMP) and Drug Supply Chain Security Act (DSCSA) compliance, contractual relationships with at least two of the three authorized wholesalers with chargeback systems in place, comprehensive insurance including commercial general liability of $5,000,000 per occurrence, and products with expiration dates of at least one year from manufacture. Evaluation weights pricing competitiveness at 75 percent, with remaining points distributed across fixed pricing (10 percent), administrative compliance (5 percent), EDI capability (5 percent), and acceptance of a 3 percent administrative fee (5 percent); the contract term is two years for new vendors with optional extensions at MMCAP's discretion, effective July 1, 2026, with performance penalties ranging from $200 to $1,500 per violation for reporting delays or onboarding failures.